A case of refractory chordoma of the clivus with a review of therapeutic targets
Authors:
- Gogo-Ogute E. IbodengGIGogo-Ogute E. Ibodeng
- Omar AlkharabshehOAOmar Alkharabsheh
- Kannan ThanikachalamKTKannan Thanikachalam
Open Access
- 10 October 2022
- journal article
- review article
- Published by Elsevier in Current Problems in Cancer: Case Reports
- Vol. 8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapiesOncoImmunology, 2017
- Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle PathwayCancer Research, 2015
- Building a global consensus approach to chordoma: a position paper from the medical and patient communityThe Lancet Oncology, 2015
- Sustained Response of a Clivus Chordoma to Erlotinib after Imatinib FailureCase Reports in Oncology, 2015
- Case reportInternational Journal of Surgery Case Reports, 2014
- Diagnosis and Treatment of ChordomaJournal of the National Comprehensive Cancer Network, 2013
- Phase II study on lapatinib in advanced EGFR-positive chordomaAnnals of Oncology, 2013
- Clival chordoma with an atypical presentation: a case reportJournal of Medical Case Reports, 2012
- Phase II Study of Imatinib in Advanced ChordomaJournal of Clinical Oncology, 2012
- Endoscopic resection of chordomas in different clival regionsActa Oto-Laryngologica, 2009